This video is an overview of our current and future direction as a Nuclear Medicine Department at the University of Texas MD Anderson Cancer Center. We would like to share our experience as an integral part of the multidisciplinary care provided for all of our cancer patients as we provide both diagnostic and therapeutic services for survival benefit and palliation.
1 CPD credit
- Multidisciplinary care is essential in the management of cancer patients and nuclear medicine in particular via hybrid imaging plays an important role in staging, response assessment and prognostication.
- Nuclear Medicine therapies provide survival benefit and palliation in multiple tumor types.
- Novel therapies such as immunotherapy provide great opportunity for improving the outcome of patients with solid tumors and we should be aware of how these treatments can affect our interpretation of PET/CT scans.
Watch the video and complete the online self-reflection form. Go to "My events" to download your certificate.
You must login to watch the video and receive CPD.
Professor Homer Macapinlac
Dr. Homer A. Macapinlac is the James E. Anderson Distinguished Professor of Nuclear Medicine and Chair of the Department of Nuclear Medicine at the University of Texas M.D. Anderson Cancer Center in Houston, Texas and holds a joint appointment in the Department of Experimental Diagnostic Imaging. He is Director of Clinical Radiotracer Production and Development at M.D. Anderson’s Center for Advanced Biomedical Imaging Research (CABIR). He joined M. D. Anderson Cancer Center in 2001 as an Associate Professor and Chief of the Section of Positron Emission Tomography. Prior to coming to M. D. Anderson, he served as clinical director of the Laurent and Alberta Gershel Positron Emission Tomography Center of Memorial Sloan-Kettering Cancer Center, in New York for six years. Dr. Macapinlac is board certified by the American Board of Nuclear Medicine, with a Certificate of Added Qualification (CAQ) in Nuclear Cardiology.